Yovanni Casablanca


Lieutenant Colonel, Air Force

Department of Primary Appointment:
School of Medicine
Gynecologic Surgery and Obstetrics
Location: Uniformed Services University of the Health Sciences, Bethesda, MD
Research Interests:
Gynecology Oncology
Office Phone


Duke University 1994-1998
Uniformed Services University of the Health Sciences 1998-2002
San Antonio Uniformed Services Health Education Consortium: Obstetrics & Gynecology Residency 2002-2006
National Capital Consortium Gynecology Oncology Fellowship 2009-2013

Career Highlights: Positions, Projects, Deployements, Awards and Additional Publications

Associate Program Director, Fellowship in Gynecologic Oncology, National Capital Consortium, 2017-current

Fellow, American College of Obstetricians and Gynecologists

Fellow, American College of Surgeons

Assistant Professor, Department of Obstetrics & Gynecology, Boonshoft School of Medicine 2013-2017

Medical Director, Department of Obstetrics & Gynecology, David Grant Medical Center 2007-2009

Ob/gyn Clerkship Director & Clinical Faculty, Family Practice Residency, David Grant Medical Center, 2006-2009

Program Chair, ACOG Armed Forces District Annual Meeting, 2014

Society of Gynecology Oncology, Full Member

Outstanding Graduate, San Antonio Uniformed Services Health Education Consortium, 2006

Alpha Omega Alpha Honor Medical Society

Representative Bibliography

Hamilton CA, Miller A, Casablanca Y, Horowitz NS, Rungruang BJ, Krivak TC, Richard SD, Rodriguez NT, Birrer MJ, Backes FJ, Geller M, Quinn M, Goodheart MJ, Mutch D, Kavanagh JJ, Maxwell GL, Bookman MA. Clincopathologic characteristics associated with long term survival in advanced epithelial ovarian cancer: an NRG Oncology/Gynecologic Oncology Group ancillary data study. Gynecol Oncol. 2017 [Epub ahead of print]

Maxwell GL, Wang G, Tian C, Bateman NW, Casablanca Y, Havrilesky LJ, Birrer MJ, Hamilton CA, Conrads TP, Darcy KM. MS7: a transcript-based diagnostic classifier for metastatic disease and worse progression-free survival in endometrioid endometrial cancer patients. Gynecol Oncol 145 (Supp 1): 12, 2017

Casablanca Y, Mieznikowski J, Day R, Hamilton CA, Conrads TP, Maxwell GL, Hood BL, Wallace A, Rose GS, McMeekin DC. Molecular profiling of tumors from stage I versus Stage III/IV cancer patients: A prediction signature for metastasis in Gynecologic Oncology Group 8024. Gynecol Oncol 133: 6, 2014

Maxwell GL, Allard J, Gadisetti CV, Litzi T, Casablanca Y, Chandran U, Darcy KM, Levine DA, Berchuck A, Hamilton CA, Conrads TP, Risinger JI. Transcript expression in endometrial cancers from Black and White patients. Gynecol Oncol 130(1):169-73, 2013

Risinger JI, Allard J, Chandran U, Day R, Chandramouli GVR, Miller C, Zahn C, Oliver J, Litzi T, Marcus C, Dubil E, Byrd K, Casablanca Y, Becich M, Berchuck A, Darcy KM, Hamilton CA, Conrads TP, Maxwell GL. Gene expression analysis of early stage endometrial cancers reveals unique transcripts associated with grade and histology but not depth of invasion. Frontiers in Oncology 3:139, 2013

Casablanca Y, Management of Dysfunctional Uterine Bleeding, Chapter, Obstet Gynecol Clin N Am 35 (2008) 219-34

Robinson RD, Casablanca Y, Pagano KE, Arthur NJ, Bates GW & Propst AM. Intracervical Block and Pain Perception During the Performance of a Hysterosalpingogram: A Randomized Controlled Trial. Obstetrics & Gynecology 109:89-93, 2007